close
close

ALX Oncology to present at Cantor Fitzgerald Global Healthcare Conference 2024





ALX Oncology Holdings (Nasdaq: ALXO), an immuno-oncology company focused on CD47 immune checkpoint pathway Therapies, has his participation in the Cantor Fitzgerald Global Healthcare Conference 2024The event will take place in New York City from September 17 to 19, 2024.

Key details of ALX Oncology’s participation include:

  • A fireside chat with analyst Li Watsek about Tuesday, September 17, 2024, 1:55 p.m. ET
  • Individual discussions with investors
  • A live webcast of the fireside chat will be available on the company’s website.
  • Archived replay available up to 90 days after the event

This conference provides ALX Oncology with the opportunity to showcase its progress and engage with the investment community.

ALX Oncology Holdings (Nasdaq: ALXO), a global focus of immuno-oncology Checkpoint immunity CD47ha announced his participation in all Cantor Fitzgerald Global Healthcare Conference 2024. The event will take place New York City from September 17 to 19, 2024.

I describe the main parts of ALX Oncology, including:

  • An informal chiacchierata with analyst Li Watsek, September 17, 2024, at 1:55 p.m. ET
  • Incontri individuali con investitori
  • A transfer towards the informal chiacchierata accessible Tramite il to web dell'azienda
  • Replay archives are available for up to 90 days after the event

This conference provides ALX Oncology with the opportunity to advance its progress and engage with the investor community.

ALX Oncology Holdings (Nasdaq: ALXO), a company specializing in immuno-oncology and therapy About the point of immunity control CD47I announced my participation on Monday Cantor Fitzgerald Global Healthcare Conference 2024. The event will be brought to Cabo en City of New York from September 17 to 19, 2024.

Details of ALX Oncology’s participation include:

  • An informal chat with analyst Li Watsek March 17 September 2024 at 1:55 p.m. ET
  • Reunions with Reversers
  • A real-time transmission from the Charla was accessible via the company’s website
  • The archived replay is available for at least 90 days after the event

This conference took place at ALX Oncology and offers the opportunity to track your progress and engage with the inverter community.

ALX Oncology Holdings (Nasdaq: ALXO), CD47 is the first CD-ROM 치료에 중점을 둔 면역 온콜로지 회사가 Cantor Fitzgerald Global Healthcare Conference 2024에 참여한다고 발표했습니다. 이 행사는 2024 September 9th 17th 19th 19th September 2024.

ALX Oncology:

  • 분석가 Li Watsek의 파이어사이드 채팅이 September 17, 2024, September 17, 19:55 (ET)This is a mistake.
  • 투자자와의 일대일 미팅
  • 회사의 웹사이트를 통한 파이어사이드 채팅의 실third 웹캐스트
  • The 90-degree show is suitable for 90 years

The current version of ALX Oncology is the first choice you like No.

ALX Oncology Holdings (Nasdaq: ALXO), an immuno-oncology company focused on treating diseases Immunity checkpoint CD47an announcement about participation in Cantor Fitzgerald Global Healthcare Conference 2024. The event ends New York from 17 to 19 September 2024.

Detailed information about ALX Oncology’s participation includes:

  • An informal discussion with analyst Li Watsek March 17 September 2024 at 1:55 p.m. ET
  • Individual reunions with investors
  • A live webinar for informal discussions, accessible via the Web de l'entreprise website
  • A Rediffusion archive is only available 90 days after the event

This conference is offered for ALX Oncology and provides an opportunity to present and interact with the investor community in advance.

ALX Oncology Holdings (Nasdaq: ALXO), an immuno-oncology company focused on CD47 immune checkpoint pathway Therapies, has increased his participation in the Cantor Fitzgerald Global Healthcare Conference 2024 announced. The event will take place in New York City from September 17 to 19, 2024 instead of.

Key details regarding ALX Oncology’s participation include:

  • A fireside chat with analyst Li Watsek on Tuesday, September 17, 2024, at 1:55 p.m. ET
  • Individual discussions with investors
  • A live webcast of the chimney maintenance accessible via the company website
  • Archived playback available for up to 90 days after the event

This conference provides ALX Oncology with the opportunity to showcase its progress and engage with the investor community.











SOUTH SAN FRANCISCO, Calif., Sept. 9, 2024 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that management will participate in the 2024 Cantor Fitzgerald Global Healthcare Conference, taking place September 17-19, 2024 in New York City.

Format: Fireside chat with analyst Li Watsek and 1×1 meetings
Date: Tuesday, September 17, 2024
Time: 1:55 p.m. ET
Link to the webcast: Available here

The live webcast of the fireside chat will be available through the Investors section of ALX Oncology's website under Events under the News and Events tab. A recording of the webcast will be archived for up to 90 days after the date of the fireside chat.

About ALX Oncology

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company helping patients fight cancer by developing therapies that block the immune checkpoint inhibitor CD47 and bridge the innate and adaptive immune systems. ALX Oncology's lead product candidate, Evorpacept, is a CD47-blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. To date, Evorpacept has been administered to over 500 subjects and has demonstrated promising activity and a favorable tolerability profile in combination with various leading anti-cancer antibodies across a range of hematologic and solid malignancies. ALX Oncology is currently focused on combining Evorpacept with anti-cancer antibodies, antibody-drug conjugates and PD-1/PD-L1 immune checkpoint inhibitors.









Frequently Asked Questions



When does ALX Oncology (ALXO) speak at the Cantor Fitzgerald Global Healthcare Conference?

ALX Oncology (ALXO) will present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 17, 2024, at 1:55 p.m. ET.


What type of presentation will ALX Oncology (ALXO) give at the 2024 Cantor Fitzgerald Conference?

ALX Oncology (ALXO) will participate in a fireside chat with analyst Li Watsek at the 2024 Cantor Fitzgerald Global Healthcare Conference.


How can investors access ALX Oncology’s (ALXO) presentation at the Cantor Fitzgerald conference?

Investors can access a live webcast of the ALX Oncology (ALXO) Fireside Chat on the Company’s website in the Investors section under the News and Events tab.


How long will the replay of the ALX Oncology (ALXO) Cantor Fitzgerald conference presentation be available?

The replay of ALX Oncology's (ALXO) presentation at the Cantor Fitzgerald Conference will be archived for up to 90 days after the fireside chat.





You may also like...